Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)
Status:
Unknown status
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Intravitreal injections of pegaptanib will induce the regression of Proliferative Diabetic
Retinopathy (PDR) and reduce the need for retinal photocoagulation.